Price Chart

Historical Price Data

View and export this data back to 2013. Start Trial.
Date Open High Low Close Volume
Oct 02, 2026 8.30 8.55 8.18 8.54 6.363M
Oct 01, 2026 8.50 8.64 8.19 8.21 4.614M
Sep 30, 2026 8.13 8.98 8.09 8.56 11.69M
Sep 29, 2026 7.80 8.10 7.80 8.05 4.138M
Sep 28, 2026 7.61 7.86 7.50 7.81 3.491M
Sep 25, 2026 8.08 8.27 7.63 7.75 6.564M
Sep 24, 2026 7.37 7.755 7.325 7.70 4.618M
Sep 23, 2026 7.95 8.01 7.19 7.44 5.564M
Sep 22, 2026 7.64 8.04 7.52 7.89 5.329M
Sep 21, 2026 7.84 7.91 7.63 7.70 3.240M
Sep 18, 2026 7.98 8.038 7.695 7.78 9.578M
Sep 17, 2026 7.585 7.945 7.585 7.87 9.364M
Sep 16, 2026 7.00 7.49 6.94 7.435 8.227M
Sep 15, 2026 6.81 7.015 6.76 7.00 2.779M
Sep 14, 2026 6.86 7.11 6.83 6.85 2.826M
Sep 11, 2026 6.77 6.92 6.76 6.85 2.061M
Sep 10, 2026 6.70 6.73 6.54 6.68 2.839M
Sep 09, 2026 6.87 6.885 6.675 6.80 3.138M
Sep 08, 2026 6.89 7.02 6.72 6.87 2.771M
Sep 04, 2026 7.12 7.27 7.08 7.10 2.193M
Sep 03, 2026 7.00 7.14 6.98 7.14 2.189M
Sep 02, 2026 6.91 7.14 6.815 7.01 2.638M
Sep 01, 2026 6.81 7.00 6.80 6.86 2.806M
Aug 31, 2026 6.934 7.00 6.602 6.93 4.136M
Aug 28, 2026 7.11 7.19 6.92 6.95 2.703M

Price Definition

The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

Read full definition.

Price Range, Past 5 Years

View Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Benchmarks

View Price Benchmarks
Start Trial
Repligen Corp. 181.70
AC Immune SA 2.725
Amgen, Inc. 403.04
Geron Corp. 1.20
Neurocrine Biosciences, Inc. 143.18

Price Related Metrics

PS Ratio 35.59
PEG Ratio -0.0496
Price to Book Value 70.16
Earnings Yield -12.87%
Market Cap 3.057B
PEGY Ratio -0.0496